Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

02 oct 2018 7:00 a.m. - 03 oct 2018 3:00 p.m.

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Measuring Impact in Patient-Centered Drug Development Conference

Session 8: Implementing Metrics - Where are We Going?

Session Chair(s)

Suzanne  Schrandt, JD

Suzanne Schrandt, JD

Founder, Chief Executive Office and Chief Patient Advocate

ExPPect, United States

Measuring the impact of patient engagement efforts is a tool for ensuring meaningful exchange and for driving toward meaningful outcomes. This session presents a frank and forward looking discussion about addressing the constraints around utilizing patient engagement metrics and new initiatives that will help to advance the field.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify challenges and constraints around measuring the impact of patient engagement
  • Describe approaches to addressing these challenges and constraints
  • Discuss the impact of key initiatives on the use of appropriate metrics to advance patient engagement

Speaker(s)

Jennifer  Miller, PhD

Patient-Centricity & Ethics in Pharma

Jennifer Miller, PhD

Yale School of Medicine, United States

Associate Professor of Medicine; Co-Director, Program for Biomedical Ethics

Theresa  Mullin, PhD

Implementing Metrics - Where are We Going?

Theresa Mullin, PhD

FDA, United States

Associate Center Director - Strategic Initiatives, CDER

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.